Inventor · disambiguated record
Michael Battles
Also filed as: BATTLES MICHAEL · BATTLES MICHAEL B · BATTLES MICHAEL BENJAMIN
5 granted patents·9 pending applications·8 citations·filing 2013–2025
71Inventor score
Top patents by PatentIndex Score
14 records- 0187US10744157B2Anti-MICA antigen binding fragments, fusion molecules, cells which express and methods of usingDARTMOUTH COLLEGE·Filed 2016·Granted Aug 18, 2020·4 cites·15 claims
- 0282US11857571B2Anti-mica antigen binding fragments, fusion molecules, cells which express and methods of usingDARTMOUTH COLLEGE·Filed 2020·Granted Jan 2, 2024·1 cites·20 claims
- 0372US12304957B2Anti-CD161 antibodies and uses thereofIMMUNITAS THERAPEUTICS INC·Filed 2024·Granted May 20, 2025·0 cites·30 claims
- 0470US12215159B2Anti-CD161 antibodies and uses thereofIMMUNITAS THERAPEUTICS INC·Filed 2024·Granted Feb 4, 2025·0 cites·30 claims
- 0569US9914767B2Cross-reactive Staphylococcus aureus antibodyARSANIS BIOSCIENCES GMBH·Filed 2013·Granted Mar 13, 2018·3 cites·21 claims
- 0663US2025243281A1Anti-cd161 antibodies and uses thereofIMMUNITAS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0759US2025215082A1Variant ch3 domains engineered for preferential ch3 heterodimerization, multi-specific antibodies comprising the same, and methods of making thereofADIMAB LLC·Filed 2023·Application pending·0 cites
- 0855US2024228588A1Variant ch1 domains and variant cl domains engineered for preferential chain pairing and multi-specific antibodies comprising the sameADIMAB LLC·Filed 2022·Application pending·0 cites
- 0951US2024317858A1Anti-cd3 antibodiesADIMAB LLC·Filed 2022·Application pending·0 cites
- 1047US2025223379A1Variant ch3 domains engineered for preferential ch3 heterodimerization, multi-specific antibodies comprising the same, and methods of making thereofADIMAB LLC·Filed 2022·Application pending·0 cites
- 1142US2016244511A1Cross-reactive staphylococcus aureus antibody sequencesARSANIS BIOSCIENCES GMBH·Filed 2014·Application pending·0 cites
- 1242US2016340415A1ANTIBODIES DIRECTED AGAINST THE LukGH (LukAB) TOXIN OF STAPHYLOCOCCUS AUREUS AND ANTIBODY SEQUENCESARSANIS BIOSCIENCES GMBH·Filed 2014·Application pending·0 cites
- 1339US2016108106A1Generation of highly potent antibodies neutralizing the lukgh (lukab) toxin of staphylococcus aureusARSANIS BIOSCIENCES GMBH·Filed 2014·Application pending·0 cites
- 1430US2018105584A1Antibody directed against immunoglobulin-binding proteins of s. aureusARSANIS BIOSCIENCES GMBH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Battles files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →